Loading...
XSHG600056
Market cap2.19bUSD
Jan 16, Last price  
10.71CNY
1D
0.09%
1Q
-2.72%
Jan 2017
-21.19%
Name

China Medicine Health Industry Co Ltd

Chart & Performance

D1W1MN
XSHG:600056 chart
P/E
15.29
P/S
0.41
EPS
0.70
Div Yield, %
2.30%
Shrs. gr., 5y
—
Rev. gr., 5y
4.60%
Revenues
38.82b
+3.28%
2,174,436,6991,929,669,9502,703,234,0272,475,160,4413,079,157,1094,790,006,2176,259,530,6257,268,599,9389,901,358,34814,829,508,15617,857,372,64020,570,225,97025,737,892,19430,102,338,55031,006,036,44735,284,824,31439,311,753,47236,234,414,70337,592,649,53238,824,430,504
Net income
1.05b
+42.47%
6,551,11172,580,00772,314,548234,853,364162,964,358189,269,048194,938,103269,003,808348,560,226484,832,049550,177,822614,453,640948,137,2871,298,524,4271,544,519,826981,345,8451,310,645,723647,057,060735,601,1571,048,039,144
CFO
859m
-47.80%
50,244,5320113,729,11800968,973,078055,431,846961,254,4260994,844,3011,022,250,3521,004,038,713509,178,805257,80701,559,304,980148,420,9841,645,872,491859,075,452
Dividend
Sep 27, 20240.02174 CNY/sh
Earnings
May 21, 2025

Profile

China Meheco Group Co., Ltd. engages in the pharmaceutical business in China and internationally. The company imports and exports China national medicines and health products; produces and distributes pharmaceutical and health care products; and operates retail chain pharmacies. Its products include bulk pharmaceutical chemicals antibiotic fermentation and chemical synthesis tablets, injections, capsules, etc.; antibiotics; medicines for the treatment of cardio-cerebrovascular diseases, chronic diseases, and diabetes; antiviral drugs; anti-infectious agents; gastrointestinal drugs; non-steroidal anti-inflammatory drugs; anti-allergic agents; specialty botanicals; western medicine preparations; Chinese patent medicines and herbal pieces; medical equipment and supplies; biological products and raw materials; chemical raw materials; and nutritional and other healthcare products. The company also plants, processes, warehouses, and transports ginseng, licorice, ephedra, rhubarb, rheum officinale, astragalus membranaceus, scutellaria baicalensis, fennel, and other herbs. China Meheco Group Co., Ltd. was founded in 1984 and is based in Beijing, China.
URL
http://www.meheco.com
IPO date
May 15, 1997
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
38,824,431
3.28%
37,592,650
3.75%
Cost of revenue
36,422,900
35,075,212
Unusual Expense (Income)
NOPBT
2,401,531
2,517,438
NOPBT Margin
6.19%
6.70%
Operating Taxes
398,435
308,159
Tax Rate
16.59%
12.24%
NOPAT
2,003,096
2,209,279
Net income
1,048,039
42.47%
735,601
13.68%
Dividends
(367,895)
(621,517)
Dividend yield
2.20%
2.41%
Proceeds from repurchase of equity
(229,541)
(6,557)
BB yield
1.37%
0.03%
Debt
Debt current
2,250,023
2,944,068
Long-term debt
3,028,441
2,621,738
Deferred revenue
(11,630)
73,976
Other long-term liabilities
2,738,952
2,188,333
Net debt
(1,340,108)
(1,550,104)
Cash flow
Cash from operating activities
859,075
1,645,872
CAPEX
(362,552)
Cash from investing activities
(299,349)
22,139
Cash from financing activities
(743,304)
FCF
490,540
2,097,504
Balance
Cash
3,867,266
4,260,347
Long term investments
2,751,305
2,855,563
Excess cash
4,677,350
5,236,277
Stockholders' equity
11,270,120
11,145,532
Invested Capital
16,967,654
15,353,908
ROIC
12.39%
14.54%
ROCE
11.09%
12.22%
EV
Common stock shares outstanding
1,495,917
1,495,880
Price
11.17
-35.17%
17.23
104.15%
Market cap
16,709,388
-35.17%
25,774,008
104.15%
EV
17,696,358
26,581,213
EBITDA
2,832,550
2,867,017
EV/EBITDA
6.25
9.27
Interest
230,842
217,581
Interest/NOPBT
9.61%
8.64%